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Four-jointed box protein 1The interaction between the Drosophila cadherins fat and dachsous is regulated by phosphorylation
of their respective ectodomains, a process catalysed by the atypical kinase four-jointed. Given that
many signalling functions are conserved between Drosophila and vertebrate Fat cadherins, we
sought to determine whether ectodomain phosphorylation is conserved in FAT1 cadherin, and also
whether FJX1, the vertebrate orthologue of four-jointed, was involved in such phosphorylation
events. Potential Fj consensus phosphorylation motifs were identiﬁed in FAT1 and biochemical
experiments revealed the presence of phosphoserine and phosphothreonine residues in its extracel-
lular domain. However, silencing FJX1 did not inﬂuence the levels of FAT1 ectodomain phosphory-
lation, indicating that other mechanisms are likely responsible.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Drosophila fat (Ft) cadherin is known to play important biolog-
ical roles in controlling growth and planar cell polarity (PCP)
through or in parallel with the Hippo pathway [1–6]. Signals are
communicated between neighbouring cells through the hetero-
typic trans-interaction of Ft with dachsous (Ds) [7–10] and it has
been proposed that the rate of growth is regulated on a cell to cell
basis depending on the different gradients of Ft/Ds across the cells
[4,7,11–13]. Ft/Ds signalling has also shown to be responsible for
PCP control [9,10,14–17] although some tissue-speciﬁc differences
have been reported [5,6].
Fine tuning of the Ft/Ds interaction is provided through phos-
phorylation catalysed by four-jointed (Fj) [7,12,13]. Several stud-
ies have shown that Fj inﬂuences the localisation of both Ft and
Ds [8–11,13,17–19], placing Fj upstream of Ft/Ds signalling [10].
Fjmediates phosphorylation of extracellular cadherin repeats in
both Ft and Ds and moreover this was shown to regulate thebinding afﬁnity between these receptors [7,13]. Biochemical anal-
yses identiﬁed that phosphorylation occurs on both serine and
threonine residues located at the seventh position following the
calcium-linker binding motif DXND(N/H) in selected cadherin
repeats [12]. Phosphorylation of some of these residues was cru-
cial for enhancing Ft/Ds binding while others appeared not essen-
tial [13]. Whether the same regulatory mechanism exists in
vertebrate Fat cadherins is presently unknown but the functional
parallels existing between Drosophila and vertebrate Fat cadher-
ins suggests this may be likely.
Much less is generally known concerning the functions of the
vertebrate Fat cadherins compared to their Drosophila counter-
parts. Four Fat cadherins exist in vertebrates with Fat4 being con-
sidered the orthologue of Ft [20–22]. However, the key functions of
Drosophila Ft in Hippo signalling appear to be shared between ver-
tebrate Fat4 and Fat1 [23–28]. Thus in an evolutionary context this
suggests that Fat4 and Fat1 may be similarly regulated, invoking a
possible role for Fjx1, the only known homologue of Fj in verte-
brates [29,30]. Moreover, functional studies showed Fjx1 to play
a role in cyst repair in polycystic kidney disease, an effect modu-
lated through the Hippo pathway [31]. This phenotype also bears
a striking similarity to the cystic kidney phenotypes manifested
in Fat1 and Fat4 null mice [32], thereby promoting a plausible role
for Fjx1 as the vertebrate ‘cadherin’ kinase.
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essential role in the regulation of the interaction between Fat1 and
its presently unidentiﬁed ligand. In this report we sought to estab-
lish if the ectodomain of human FAT1 was phosphorylated and to
determine what role FJX1 plays in this process.
2. Experimental procedures
2.1. Cell lines and culture
The T4-2 subline of HMT-3522 human breast epithelial cells
were obtained from the ECACC and cultured in DMEM (Lonza)
supplemented with 10% foetal bovine serum (Sigma–Aldrich).
2.2. Antibodies
Polyclonal (pAb) and monoclonal (mAb) anti-FAT1 and isotype-
matched controls were as previously described [33,34]. Antibodies
against phosphoserine (pSer) (mAb clone PCR45, P5747, Sigma;
mAb clone 4A4, 05-1000, Millipore; rabbit pAb, 61-8100, Invitro-
gen) and phosphothreonine (pThr) (rabbit pAb 9381, Cell Signaling
Technologies) were purchased as indicated.
2.3. Electrophoresis and Western blotting
Soluble cell lysates were prepared as described [35] and immu-
noprecipitated where indicated [34]. Some samples were treated
with k-protein phosphatase [34]. Samples were applied to com-
mercial PAGE gels (NuPAGE Novex 3–8% Tris–Acetate) and trans-
ferred to nitrocellulose membranes [34]. Membranes were blocked
overnight at 4 C with 0.5% fatty acid free BSA (PAA) in TTBS (0.05%
v/v Tween 20 in Tris-buffered saline) prior to incubation with
either anti-pSer or anti-pThr antibodies diluted in the blocking buf-
fer, overnight at 4 C. Alternatively 5% w/v non-fat skim milk in
TTBS was used for blocking and incubations for all other antibod-
ies. Bound antibodies were detected with anti-mouse or anti-rab-
bit IgG HRP-conjugates (BioRad) and ECL signals developed [33].
For re-probing, membranes were treated with 0.2 M NaOH for
5 min at RT to strip bound antibodies. Densitometric analyses
employed MultiGuage software (Fujiﬁlm Life Sciences).
2.4. siRNA and qRT-PCR analysis
Synthetic siRNA duplexes targeting human FJX1 and controls
(Table S1) were purchased from GenePharma (Shanghai, PRC)
and used to transfect cells as described [36]. Total RNA was
extracted using the minispin RNA kit (GE healthcare) and 1 lg used
in a reverse transcription reaction (BioScript™, Bioline) according
to the manufacturer’s instructions. Quantitative RT-PCR was per-
formed using the SensiMix™ SYBR Kit (Bioline) with speciﬁc prim-
ers for the FJX1 gene (forward, 50-GTGTGATTCGGGTTTTAGGG-30
and reverse, 50-CTGTACTCGTGGCTGCAGTT-30). Reactions were
carried out as described before [36].
2.5. Stable knockdown of FJX1 using shRNA
MicroRNA-based short hairpin (shRNA-miR) constructs directed
against FJX1 were purchased from Thermo Scientiﬁc (pGIPZ, Open
Biosystems) and plasmid DNA prepared (Purelink HiPure midi-
prep kit, Invitrogen). Of the six plasmids provided, preliminary
transfection experiments showed three effectively knocked down
FJX1 mRNA levels compared to controls (Table S2). The functional
plasmids were then used to prepare lentiviral particles in 293FT
packaging cells. Brieﬂy, cells were seeded and treated with 1 mg/
ml G418 the day before transfection using Lipofectamine 2000
(Invitrogen) and a mixture of shRNA-miR encoding plasmid, pSAX2and pVSV-G. Cell free supernatants were prepared after 48 h [36]
and supplemented with hexadimethrine bromide (8 lg/ml; Sigma)
before transduction using ‘spinfection’ [37]. Cells were subjected to
selection with 2 lg/ml of puromycin for 48 h, reducing the concen-
tration to 0.2 lg/ml thereafter for maintenance. The efﬁciency of
the transduction was conﬁrmed by over 95% tGFP expression using
ﬂow cytometry (FACSAria II instrument, BDBiosciences) after one
week of antibiotic selection.
3. Results
3.1. Potential ectodomain phosphorylation motifs are conserved in
FAT1 cadherin
Guided by Drosophila studies we ﬁrst sought to deﬁne if poten-
tial Fj-phosphorylation motifs were present in FAT1. Simon and
colleagues had previously reported 11 of the 34 cadherin repeats
in Ft contained serine or threonine residues within the context of
a Fj substrate consensus motif [13]. Thus far only four of the phos-
phorylation sites have been experimentally validated all involving
serine residues. The authors also examined several species of ver-
tebrate Fat4 identifying a number of conserved serine and/or thre-
onine residues conforming to the Fj-motifs. We extended this
analysis to include FAT1.
Sequence alignments of the cadherin domains from Ft, FAT1
and FAT4 are shown in Fig. S1 and the ﬁndings summarized in
the schematic depiction in Fig. 1. The analysis corroborated the
presence of conserved serine or threonine residues in FAT4, where
ﬁve out of the eight putative phosphorylation residues overlap
with those of Ft [13]. Comparison against FAT1 also showed that
from the total of nine potentially phosphorylated residues, two res-
idues in cadherin domains 13 and 28 overlap with the sites found
in Ft and FAT4.
3.2. FAT1 cadherin ectodomain is phosphorylated on both serine and
threonine residues
Ft has been shown to undergo proteolytic processing to yield a
non-covalently bound heterodimer [38]. Our recent study con-
ﬁrmed that FAT1 was also cleaved yielding proteolytic fragments
of 430 and 85 kDa that comprise a non-covalently linked heterodi-
mer [34,36]. As a consequence of this event, the intact FAT1 mole-
cule (p500) can be readily distinguished from the two component
chains that comprise the heterodimer using Western blotting;
namely an extracellular fragment (p430) and the transmem-
brane/intracellular fragment (p85) (Fig. 2A).
Presently there are no reports indicating whether phosphoryla-
tion occurs in the ectodomain of any vertebrate Fat cadherin. To
determine if the FAT1 ectodomain was phosphorylated we
employed broadly speciﬁc antibodies reactive against phosphoa-
mino acids and used these to probe against immunoprecipitates
of FAT1. Cell lysates were prepared from FAT1-expressing T4-2
cells and aliquots subjected to immunoprecipitation using mAbs
directed against the aminoterminus (NTD7) or carboxylterminus
(CTD7) of FAT1 together with an isotype control (11H5). The sam-
ples were then processed for Western blotting using antibodies
against pSer or pThr.
In the course of our experiments we evaluated three different
antibodies directed against pSer; two mAb clones, PSR45 and
4A4 respectively, together with a rabbit pAb. Both pSer mAbs spe-
ciﬁcally decorated two high Mr bands present in FAT1 immunopre-
cipitates. Similarly, the pAb directed against pThr reacted
speciﬁcally against the same high Mr bands but the anti-pSer
pAb displayed no signiﬁcant reactivity (Fig. 2B, left panels). These
bands correspond to the uncleaved p500 form and the p430 chain
of the FAT1 heterodimer (refer to Fig. 2A). To conﬁrm the
Fig. 1. Conservation of extracellular phosphorylation sites in Fat cadherins. Schematic shows the domain organization of Drosophila Ft along with human FAT4 and FAT1
cadherins. The protein domains depicted were determined using ExPasy-PROSITE (http://prosite.expasy.org/). An analysis of Fj-dependent phosphorylation motifs (Fig. S1)
identiﬁed extracellular cadherin (EC) domains with potentially phosphorylated serine and threonine residues highlighted in blue and green respectively. Validated
phosphorylated residues from Drosophila Ft [12,13] are ﬂagged with . TM, transmembrane domain.
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quently stripped and subjected to secondary blotting. Antibodies
directed against the carboxylterminus of the molecule (FAT1-C
pAb) showed strong speciﬁc reactivity against a single band resolv-
ing identically to p500 (Fig. 2B, right panels). As expected, the p430
chain was not recognised with the anti-FAT1-C pAb since it
entirely lacks carboxylterminal residues (Fig. 2A) [34]. The speciﬁc
reactivity against pSer and pThr corresponding to the p500 and
p430 forms of FAT1 therefore suggests that FAT1 is phosphorylated
on serine and threonine residues. Since p430 inherently contains
no cytoplasmic residues, phosphorylated residues are clearly pres-
ent in the extracellular domain of FAT1. It can also be noted that
the relative intensity of the two bands appeared to differ for each
antibody reagent, with serine reactivity being notably more prom-
inent in p500 whereas threonine reactivity was relatively stronger
in p430. The signiﬁcance of this observation is elaborated upon in
Section 4.
To conﬁrm the reactivity observed against pSer/pThr represents
bona ﬁde phosphorylation, FAT1 immunoprecipitates were treated
with k-protein phosphatase prior to Western blotting. As shown in
Fig. 2C, k-protein phosphatase ablated the signals produced by the
pSer PSR45 mAb and also the pThr pAb. In contrast the signals pro-
duced with the 4A4 pSer reagent were not signiﬁcantly affected by
phosphatase treatment. Importantly as the immunoreactivity of
PSR45 mAb and pThr pAb against the p430 band was dependent
upon phosphorylated residues, this conﬁrms the presence of both
pSer and pThr in the FAT1 ectodomain. Consequently these two
reagents were employed in subsequent experiments.
3.3. FJX1 does not catalyse the ectodomain phosphorylation of FAT1
In order to elucidate whether FJX1 was responsible for the
phosphorylation of the FAT1 ectodomain, we used two separate
RNAi technologies: transient siRNA transfection and stable shRNA
knockdown. We evaluated three different siRNA duplexes designed
to target FJX1 along with a non-targeting sequence (NTS). T4-2
cells were transfected and knockdown efﬁciency evaluated using
qRT-PCR. Following treatment of cells with the three individual
duplexes we recorded up to 90% reduction in the measured levels
of FJX1 mRNA indicating effective knockdown (Fig. 3A). On thisbasis, we pooled all three siRNA duplexes for subsequent
experiments.
We then proceeded to determine if depletion of FJX1 could
affect the phosphorylation of FAT1 ectodomain. Cells transfected
with pooled FJX1 siRNA or NTS duplexes were lysed after 72hrs
and immunoprecipitated as described for Fig. 2 followed by Wes-
tern blotting for pSer or pThr. Thereafter, membranes were reblot-
ted with pAbs directed against the aminoterminus of FAT1.
Consistent with prior experiments, the p500 and p430 FAT1 bands
were reactive with both antibodies (Fig. 3B, upper panel). Densi-
tometry was then used to quantitate the results of the siRNA
experiments where signals for pSer or pThr were expressed as a
ratio of the total FAT1 recovered in each immunoprecipitate. Com-
parison of the reactivity obtained with control duplexes versus
cells depleted of FJX1 showed no changes for either pSer or pThr
signals in three replicate experiments (Fig. 3C). Together these
results suggested that FJX1 was dispensable for ectodomain phos-
phorylation events in FAT1.
As further substantiation of this result, we employed a different
system to silence FJX1 expression in T4-2 cells. Using lentiviral-
mediated transduction of shRNA-miRs we derived stable cell pop-
ulations of control GFP cells (GFP only containing a non-targeting
miR) together with two independent miR sequences targeting
FJX1 (FJX1–3, FJX1–6). Analysis by qRT-PCR conﬁrmed that FJX1
mRNA levels has been reduced (Fig. 4A). Sequential analysis of
immunoprecipitates using ﬁrst pSer and then pThr reagents
showed reactivity against FAT1 as before but there was no dimin-
ished reactivity evident in either population of stable FJX1 knock-
down cells (Fig. 4B). Thereafter re-probing of the membranes with
anti-FAT1 antibodies, ﬁrst antibodies against the aminoterminus
(anti-N-FAT1 reactive against p500 and p430) and then the carb-
oxylterminus (anti-C-FAT1 reactive against p500) conﬁrmed both
the presence of FAT1 and the speciﬁcity of the immunoprecipita-
tion reactions. Densitometry was then used to quantitate the
results of the shRNA experiments. Each FAT1 high Mr band was
analysed individually with results indicating no signiﬁcant differ-
ences for either p430 or p500 bands for either serine or threonine
phosphorylation (Fig. 4D). Like the results obtained with siRNA, the
shRNA experiments also support the conclusion that FAT1 phos-
phorylation does not involve FJX1.
Fig. 2. FAT1 cadherin is phosphorylated on its ectodomain. (A) Schematic showing the known forms of the FAT1 protein, the intact full length protein (p500) and the cleaved
FAT1 heterodimer (non-covalently linked p430 and p85 chains). (B) Immunoprecipitates prepared from T4-2 cell lysates were subjected to Western blotting. The left panels
show immunoprecipitates (I.P.) using either FAT1 speciﬁc mAbs (NTD7 and CTD7) or an isotype control mAb (11H5) blotted with either anti-phosphoserine mAb (clones
PSR45 or 4A4) or an anti-phosphothreonine pAb. The membranes were then stripped with NaOH and reblotted for FAT1 using a pAb against the carboxylterminal domain of
FAT1 (Rbt-anti-C-FAT1) to conﬁrm the presence of FAT1 protein (p500) (right panels). (C) Determination of the levels of phospho-speciﬁc reactivity in FAT1 protein bands
using densitometry. Reactivity for each of phospho-speciﬁc reagents was determined after subjecting immunoprecipitates to Mock treatment (tx) or treatment with k-protein
phosphatase (k-Phosphatase tx). The p430 and p500 bands were analysed separately with results expressed as a relative ratio of densitometric units of each phospho-speciﬁc
antibody compared to the total FAT1 signal (RU). The results are presented as the mean ± S.E.M. from 6 determinations in 3 independent experiments (⁄⁄⁄p < 0.001 and
⁄⁄⁄⁄p < 0.0001 using Students’ t-test).
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Enzymatic phosphorylation of proteins is the most common
post-translational modiﬁcation but reports of regulatory events
involving phosphorylation in the extracellular milieu are limited.
Nevertheless some interest has been generated in extracellular
protein kinases, the so called ecto-protein kinases (reviewed in
[39]), existing either tethered to the membrane [40,41] or secreted
[42]. Moreover, there is evidence to suggest that extracellular
phosphorylation events are important in the broad biological con-
text with diverse substrates including extracellular moieties of
plasma membrane receptors and secreted proteins [43–47]. The
interaction between Drosophila Ft and Ds cadherins now joins the
list of these examples [12,13]. The discovery of Fj acting directly
to catalyse their phosphorylation serves to resolve the nature ofthe functional relationship between Ft, Ds and Fj [7,12,13,16].
The question then arises whether this regulatory mechanism also
exists in vertebrates.
In the mouse brain there is overlap of expression of the verte-
brate homologues Fat4/Dcsh1 and Fjx1 [30]. Additionally it was
demonstrated that Fat4 and Dcsh1 physically interact within the
context of the mouse brain cortex [48]. Moreover, it was shown
that Fat4 and Dcsh1 interact in a heterophilic manner [48]. Besides,
there are indications that functional relationships exist between
Fat4 and other vertebrate Fat cadherins, particularly Fat1, together
with reports that Fjx1 null mice may phenocopy Fat1 and Fat4-null
mice. Surprisingly little is known about the fundamental function
of Fjx1 and no reports have presently considered whether it might
act as a kinase. To our best knowledge this study represents the
ﬁrst foray to investigate this process.
Fig. 3. Assessment of the role of FJX1 in FAT1 cadherin ectodomain phosphorylation using siRNA. (A) Assessment of siRNA-mediated depletion of FJX1 mRNA using qRT-PCR.
T4-2 cells were transfected with three siRNA duplexes targeting FJX1 together with non-targeting sequence (NTS) duplexes for 72 h. Measurement of mRNA showed that all
three duplexes targeting FJX1 produced a 90% reduction in FJX1 levels compared to controls (mean ± S.E.M. from triplicate determinations, ⁄p < 0.05 using Students’ t-test).
T4–2 cells were then transfected with a pool of all three siRNA duplexes targeting FJX1, lysed after 72 h and the samples immunoprecipitated (I.P.) using mAbs against FAT1
or a control mAb as described in Fig. 2. Membranes were ﬁrst blotted with anti-pSer mAb (clone PSR45) (B) or anti-pThr pAbs (C), followed by stripping and re-probing of
membranes using a rabbit pAb recognizing the aminoterminus of FAT1 (Rbt anti-N-FAT1). (D) Densitometric analysis of serine and (E) threonine phosphorylation levels
compared to total levels of FAT1 protein. The p430 and p500 bands were analysed separately with results expressed as a relative ratio of densitometric units of each phospho-
speciﬁc antibody compared to the total FAT1 signal (RU). Results represent the mean ± S.E.M. from 2 determinations in 3 independent experiments.
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genes encode type II transmembrane proteins [49,50]. Fjx1 consists
of a single exon gene with 42% protein sequence identity between
Fj and Fjx1, and 90.4% identity between human FJX1 and mouse
Fjx1 (determined using the LALIGN program; http://embnet.vital-
it.ch/software/LALIGN_form.html). With this high level of homol-
ogy it is not surprising there are also structural and possible func-
tional similarities evident between Fj and Fjx1. The site of Fj kinase
activity has been reported to be the Golgi due to the strong local-
isation to this organelle [12,50]. However, earlier reports showed Fj
was cleaved close to the N-terminus and secreted from cells
[29,51,52]. Similarly, transfection studies also showed murine
and human Fjx1 are also secreted [49,53]. Nevertheless human
FJX1 also showed prominent expression in the Golgi in transfection
experiments [53]. However since the experiments for both Fj and
Fjx1 have been reported in the context of transfection, it may just
be that overexpressed Fj/Fjx1 protein is overwhelming the secre-
tory apparatus leading to Golgi accumulation. Notably no reports
have currently established the location of endogenous Fjx1 proteinwith one group remarking they failed to detect endogenous FJX1
protein expression, even with validated bespoke antibodies [53].
Our own experiments with commercially sourced antibodies failed
to identify any speciﬁc endogenous FJX1 protein bands in either
cell lysates or conditioned cell media. More work is therefore
required to address this point.
The possibility that FJX1 acts as a kinase has been presently
ignored in literature [53]. Ishikawa et al. ﬁrst identiﬁed Fj as a
kinase but notably it appears entirely different in sequence to
the classical Ser/Thr kinases and lacks a recognisable kinase
domain [12]. As expanded in the Introduction, it appears entirely
plausible that the interaction of either FAT1 and/or FAT4 with their
ligands is regulated by ectodomain phosphorylation catalysed by
FJX1. Certainly some positional overlap exists in the location of
the phosphorylation motifs in Ft and Fat4 ([13] and Fig. 1/S1) sup-
porting the idea of the likely importance of phosphorylation in the
interaction between Fat4 and Dcsh1. In FAT1 we identiﬁed a total
of nine potential Fj motifs and although FAT1 and FAT4 have a sim-
ilar domain organisation, there is a more limited positional align-
Fig. 4. Effects of shRNA-miR-mediated knockdown of FJX1 on FAT1 ectodomain phosphorylation. (A) qRT-PCR assessment of FJX1 mRNA levels in T4-2 cells stably transduced
with two independent FJX1-targeting shRNA-miRs (FJX1–3 and FJX1–6) compared to GFP (control)-transduced cells (⁄⁄⁄p < 0.001 and ⁄⁄⁄⁄p < 0.0001 for differences between
FJX1-shRNA-miR and controls using Students’ t-test). (B) Sequential Western blotting analysis of pSer and pThr residues present in FAT1 immunoprecipitates isolated from
control (GFP) and the two independent FJX1 shRNAmiR-transduced cell lines. (C) Densitometric analysis of serine and (D) threonine phosphorylation levels compared to total
levels of FAT1 protein. The p430 and p500 bands were analysed separately with results expressed as a relative ratio of densitometric units of each phospho-speciﬁc antibody
compared to the total FAT1 signal (RU). The results of both FJX1–3 and FJX1–6 shRNA-miR transduced cell lines were combined and compared against GFP controls with
results representing the mean ± S.E.M. from 2 determinations in 3 independent experiments (no statistically signiﬁcant differences obtained).
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alone could not exclude the possibility that FJX1 has a role in phos-
phorylation of the ectodomain of either FAT1 or FAT4 given the
entire lack of knowledge of this process in vertebrates.
Given the enormous size of FAT1 and the inherent difﬁculties
this imposes in genetic manipulation, we exploited its unique bio-
chemical characteristics, namely cleavage and non-covalent hete-
rodimerisation [34] permitting the unequivocal identiﬁcation of
the FAT1 ectodomain. This is critical to consider given the intracel-
lular domain of FAT1 is known to be highly phosphorylated [34]
and this would likely confound any analysis of phosphorylation.
Phosphorylation analysis of FAT1 protein showed both the p430
and p500 protein bands contained phosphorylated serine and thre-
onine residues. Importantly as p430 represents the ectodomain of
the protein, these results established that the ectodomain of FAT1
is multiply phosphorylated. Serine phosphorylation signals were
signiﬁcantly greater in p500 consistent with previous reports that
the Fat1 intracellular domain is phosphorylated [12,38]. In com-
parison, more pThr signals were evident in p430 suggesting that
ectodomain phosphorylation may be weighted towards modiﬁca-
tion of threonine residues. Neverthless, how these phosphorylation
events occur remains undetermined since independent approachesto deplete cells of FJX1 failed to alter the overall levels of FAT1
ectodomain phosphorylation. The regulatory mechanism involving
these phosphorylation events may be complex and we cannot
exclude the possibility that FJX1 might phosphorylate small pro-
portion of the total phosphorylated residues in FAT1. Notwith-
standing this limitation, as the ﬁrst example to substantiate
ectodomain phosphorylation in vertebrate Fat cadherins we antic-
ipate our results will facilitate further research into this rapidly
progressing ﬁeld.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.
2014.08.014.
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